
OS Therapies Delivers Impressive Third Quarter 2024 Financial Results and Exciting Business Update
OS Therapies Reports Financial Results for Third Quarter 2024 Key Highlights: OS Therapies, Inc. (NYSE-A: OSTX) announced its financial results for the third quarter of 2024, which ended on September 30th. The Company completed its initial public offering during this period and successfully dosed the final patient in its Phase 2b clinical trial of OST-HER2…